C12N 2750/14361
Methods of inactivation or attenuation
C12N2750/14361 (Methods of inactivation or attenuation) appears on 16 US grants and 21 published applications in this corpus.
Search patents in C12N- Granted patents
- 16
- Published applications
- 21
- Assignees
- 18
- Inventors
- 69
- Latest grant
- 27 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 2 |
| 2014 | 0 | 1 |
| 2015 | 2 | 1 |
| 2016 | 1 | 3 |
| 2017 | 0 | 1 |
| 2018 | 1 | 2 |
| 2019 | 2 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 2 |
| 2023 | 1 | 2 |
| 2024 | 2 | 2 |
| 2025 | 2 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Virus inactivation method, method for manufacturing protein drug, and system for purifying solution27 Jan 2026US 12,533,413 B2Able Corporation
- Protoparvovirus compositions comprising a protoparvovirus variant VP1 capsid polypeptide and related methods12 Aug 2025US 12,383,615 B2Carbon Biosciences, Inc.
- Canine parvovirus (CPV) nanobody CPV-VHH-H1 and use thereof29 Jul 2025US 12,371,476 B2Institute of Animal Sciences of Caas
- Bocaparvovirus small noncoding RNA and uses thereof4 Jun 2024US 11,999,965 B2University of Iowa Research Foundation
- Method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin9 Apr 2024US 11,952,603 B2Scientific Protein Laboratories, LLC
- Modified oncolytic parvovirus h-1pv with an enhanced fitness and superior anticancer activity21 Aug 2025US 2025/0262296 A1
- Bocaparvovirus small noncoding rna and uses thereof21 Nov 2024US 2024/0384294 A1University of Iowa Research Foundation
- Protoparvovirus compositions comprising a protoparvovirus variant vp1 capsid polypeptide and related methods31 Oct 2024US 2024/0358820 A1Carbon Biosciences, Inc.
- Virus inactivation method, method for manufacturing protein drug, and system for purifying solution2 Nov 2023US 2023/0346944 A1Able Corporation
- Canine parvovirus (cpv) nanobody cpv-vhh-h1 and use thereof22 Jun 2023US 2023/0192815 A1Institute of Animal Sciences of Chinese Academy of Agricultural Sciences
Most cited
By later US patents
- Parvovirus protein presenting capsids66US 5,916,563 AUnited States of America · 1999
- Bocaparvovirus small noncoding RNA and uses thereof6US 11,142,775 B2University of Iowa Research Foundation · 2021
- Cell cultures4US 4,021,302 ABurroughs Wellcome Co. · 1977
- Method for large scale production and purification of parvovirus1US 10,266,810 B2Deutsches Krebsforschungszentrum · 2019
- Method for inactivating non-enveloped viruses using a viricide-potentiating agent with a photoactivatible virucide1US 5,663,043 AHemasure, Inc. · 1997